The Cancer Genome Atlas (TCGA) data demonstrated that MALAT1 was highly expressed in GC (Supplementary Fig. 3A), and survival curve analysis with GEO dataset showed MALAT1 expression was negatively correlated with post-progression survival time of GC patients (Supplementary Fig. 3B). This evidence concerns the gene MALAT1 and gastric cancer.